Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2021

01-01-2021 | Niemann-Pick Disease | Images

Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease

Authors: Sandip Bartakke, Amit Nisal, Vibha Bafna, Aashna Valecha

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2021

Login to get access

Excerpt

A 2-month-old male child, presented with 1 month history of pallor and poor weight gain. On physical examination, there was pallor, and moderate hepatosplenomegaly (liver 6 cm and spleen 4 cm palpable below the costal margin). Hemogram showed Hb of 50 gm/L, WBC count of 7.8 × 109/L, platelet count of 53 × 109/L. Liver function tests were deranged with total bilirubin of 4.88 mg/dl, AST 298 IU/L and ALT of 158 IU/L. He had prolonged PT (> 180 s) and APTT (> 180 s) and low fibrinogen level of 108 mg/dl. Serum triglycerides were 392 mg/dl and ferritin was markedly elevated at 8460 ng/ml. In view of above findings, a diagnosis of Hemophagocytic Lymphohistiocytosis (HLH) was suspected. Bone marrow examination revealed infiltration with macrophages which showed eccentric nuclei and vacuolated cytoplasm (Fig. 1), highly suggestive of lipid storage disorder. Evidence of phagocytosis of erythroid precursor cells and lymphocytes by histiocytes was also seen (Fig. 2). Enzyme studies for Gaucher and Niemann-Pick disease were normal. The patient succumbed to progressive liver failure within 10 days of admission. Next generation sequencing from patient’s stored DNA revealed a pathogenic homozygous mutation c.193C > T(p.Arg65Ter) in exon 3 of LIPA gene leading to the diagnosis of Wolman disease (WD).
Metadata
Title
Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease
Authors
Sandip Bartakke
Amit Nisal
Vibha Bafna
Aashna Valecha
Publication date
01-01-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01350-4

Other articles of this Issue 1/2021

Indian Journal of Hematology and Blood Transfusion 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine